Cargando…
Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts
A vaccine capable of protecting at-risk persons against infections due to Cryptococcus neoformans and Cryptococcus gattii could reduce the substantial global burden of human cryptococcosis. Vaccine development has been hampered though, by lack of knowledge as to which antigens are immunoprotective a...
Autores principales: | Specht, Charles A., Lee, Chrono K., Huang, Haibin, Tipper, Donald J., Shen, Zu T., Lodge, Jennifer K., Leszyk, John, Ostroff, Gary R., Levitz, Stuart M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701832/ https://www.ncbi.nlm.nih.gov/pubmed/26695631 http://dx.doi.org/10.1128/mBio.01905-15 |
Ejemplares similares
-
Vaccination with Recombinant Cryptococcus Proteins in Glucan Particles Protects Mice against Cryptococcosis in a Manner Dependent upon Mouse Strain and Cryptococcal Species
por: Specht, Charles A., et al.
Publicado: (2017) -
Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles
por: Specht, Charles A., et al.
Publicado: (2022) -
Immunological correlates of protection following vaccination with glucan particles containing Cryptococcus neoformans chitin deacetylases
por: Wang, Ruiying, et al.
Publicado: (2023) -
Robust Stimulation of Humoral and Cellular Immune Responses following Vaccination with Antigen-Loaded β-Glucan Particles
por: Huang, Haibin, et al.
Publicado: (2010) -
Cryptococcus neoformans Cda1 and Cda2 coordinate deacetylation of chitin during infection to control fungal virulence
por: Upadhya, Rajendra, et al.
Publicado: (2021)